Ayman El-Mohandes
Overview
Explore the profile of Ayman El-Mohandes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
2615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White T, Wyka K, Rabin K, El-Mohandes A
Vaccine X
. 2024 Nov;
21:100576.
PMID: 39555242
Objectives: To evaluate changes in public trust in the science behind COVID-19 vaccines in the United States (US) from 2021 to 2023, and to assess how loss of a family...
2.
White T, Lazarus J, Rabin K, Ratzan S, El-Mohandes A
Vaccine
. 2024 Oct;
42(26):126475.
PMID: 39476474
Vaccine information fatigue, exacerbated by the infodemic, misinformation, and cultural influences, hampers public responsiveness to the uptake of vaccines for COVID-19 and other vaccine-preventable diseases. This cross-sectional study of 23,000...
3.
White T, Borrell L, El-Mohandes A
J Racial Ethn Health Disparities
. 2024 Oct;
PMID: 39468002
This review of reviews examines the role of socioeconomic status (SES) indicators on health inequities among different racial and ethnic groups in the United States (US) between 2019 and 2023....
4.
Lazarus J, White T, Wyka K, Ratzan S, Rabin K, Larson H, et al.
Nat Med
. 2024 Apr;
30(6):1559-1563.
PMID: 38684861
It is unclear how great a challenge pandemic and vaccine fatigue present to public health. We assessed perspectives on coronavirus disease 2019 (COVID-19) and routine immunization as well as trust...
5.
El-Mohandes A, Wyka K, White T, El-Sadr W, Rauh L, Vasan A, et al.
J Health Commun
. 2023 Jun;
28(sup1):34-44.
PMID: 37390011
COVID-19 vaccination has resulted in decreased hospitalization and mortality, particularly among those who have received a booster. As new effective pharmaceutical treatments are now available and requirements for non-pharmaceutical interventions...
6.
Lazarus J, Pujol-Martinez C, Kopka C, Batista C, El-Sadr W, Saenz R, et al.
Clin Microbiol Infect
. 2023 Apr;
30(5):576-581.
PMID: 37011809
Background: Limitations of current global health governance revealed during the COVID-19 pandemic can inform the ongoing deliberations of an international treaty on pandemics. Objectives: To report on WHO definitions for...
7.
El-Sadr W, Vasan A, El-Mohandes A
N Engl J Med
. 2023 Feb;
388(5):385-387.
PMID: 36724378
No abstract available.
8.
Lazarus J, Wyka K, White T, Picchio C, Gostin L, Larson H, et al.
Nat Med
. 2023 Jan;
29(2):366-375.
PMID: 36624316
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine hesitancy remains substantial, fueled in part...
9.
Lazarus J, Abdool Karim S, Batista C, Rabin K, El-Mohandes A
BMJ
. 2023 Jan;
380:8.
PMID: 36596572
No abstract available.
10.
Lazarus J, Romero D, Kopka C, Karim S, Abu-Raddad L, Almeida G, et al.
Nature
. 2022 Nov;
611(7935):332-345.
PMID: 36329272
Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic. Here we convened, as part of this Delphi study,...